Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s):  CGNSF

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments for potentially allowing early diagnosis of dementia.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Are we halted?

Nope, that was weird!  rate and reply

Are we halted?

Offer is showing $1.50  rate and reply

RE:Cognetivity Sees Pilot Program Transition Into Commercial Ag

Just holding, waiting for them to continue Advancement. Adoption takes time but someone has been accumulating the stock..  rate and reply
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

New Press Release - Cognetivity Neurosciences CFO to Speak at InterSystems Global Summit in Seattle on June 23, 2022

Dr. Thomas Sawyer is set to Deliver a Keynote Speech Alongside Senior Executives from InterSystems and Leading US Healthcare Organizations at the Healthcare Leadership Conference as Part of the InterSystems Global Summit in Seattle, WashingtonVANCOUVER, BC, June 20, 2022 /CNW/ - article.

New Press Release - Cognetivity Neurosciences CEO to Deliver Keynote Speech at Collision 2022 in Toronto

Dr. Sina Habibi to Present on the HealthConf Stage at Collision Conference, One of the World's Largest Technology ConferencesVANCOUVER, BC, June 16, 2022 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB), a technology company that article.

Cognetivity Sees Pilot Program Transition Into Commercial Ag

A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences. The firm this morning revealed that its previously announced pilot program with PRIME Health has lead more

Cognetivity To Deploy Cognitive Assessment Tool Across Large

Cognetivity Neurosciences continued to take the Middle East by storm this morning. The firm has continued its pattern of signing with health care providers in the region, this time signing with more

Dementia figures

Globally, dementia costs US$ 1.3 trillion and is projected to increase to US$ 1.7 trillion by 2030, or US$ 2.8 trillion if corrected for increases in care costs.  rate and reply

Cognetivity To Deploy Flagship Assessment Tool At Florida-Ba

The rollout of Cognetivity Neurosciences’ flagship product, the CognICA cognitive assessment tool, continues. The firm this morning announced another arrangement in the United States, that will more

New client Beyond Geriatrics in Florida  rate and reply

Cognetivity To Study Use Of Cognitive Tool To Detect Concuss

Cognetivity Neuroscience is looking to expand the scope of its cognitive testing platform. The company this morning announced that it will be undertaking a new study with Durham University, as well more

Two management

Why don't you put out at PR saying you don't give a F... about shareholders... because your friggin silence is not golden  rate and reply

To management

Hey management just don't post the news. A few of your own words where the company is headed would be most appreciated...  rate and reply

Greatly undervalued

It will soon be noticed and rewarded for its accomplishments.  rate and reply

Cognetivity Continues Push Into Middle East With Pilot Proje

Cognetivity Neurosciences continues to expand its footprint within the Middle East. This morning, the company indicated that it has entered into a collaboration agreement with PRIME Health, whom is more

Cognetivity Neurosciences Signs Commercial Deal With Dubai H

Cognetivity Neurosciences continues to expand the deployment of its Integrated Cognitive Assessment, or ICA. The firm this morning announced that it has reached a commercial arrangement with the more

RE:I said it before and I'll say it again

Agreed, if rollout of CognIGA gains steam the cost savings on the healthcare system WILL be massive. This alone should be Government focus, especially post pandemic where most Countries are more

I said it before and I'll say it again

The potential here is through the roof.  rate and reply

US$6.3B US/UK annual market opportunity more

Cognetivity Signs Commercial Agreement With Emirates Health

Cognetivity Neurosciences has entered the mainstream. The company this morning announced that it has signed a commercial agreement with Emirates Health Services, the main federal provider of more